P-85: Effect of Metformin on Anti-Mullerian Hormone (AMH) Level in Women with Infertility and Polycystic Ovary Syndrome

Authors

  • F Foroozanfard Department of Obstetrics and Gynecology - IVF Center, School of Medicine, Kashan University of Medical Sciences, Kashan, Iran
  • K Hosseini School of Medicine, Kashan University of Medical Sciences, Kashan, Iran
  • M Samimi Department of Obstetrics and Gynecology, School of Medicine, Kashan University of Medical Sciences, Kashan, Iran
  • M Sehhat Department of Statistics, School of Medicine, Kashan University of Medical Sciences, Kashan, Iran
  • Z Sadat Department of Midwifery, School of Midwifery, Kashan University of Medical Sciences, Kashan, Iran
Abstract:

Background Women with PCOS have increased AMH levels due to accumulated preantral and small antral in follicles. Ovulation improvement following decrease in levels of AMH could accure in these patients. The purpose of this study was to evaluate the effect of metformin on anti-Mullerian hormone levels in women with polycystic ovary syndrome and infertility MaterialsAndMethods This randomized clinical trial study was done on 30 infertile patients with polycystic ovary syndrome (using the Rotterdam criteria) in 1393, in infertility center of Shahid Beheshti hospital in kashan. Demographic data included age, BMI, history of abortion and contraception, and hirsutism were recorded. Metformin 1, 500 mg for 8 weeks were prescribed, then AMH level was checked before and after treatment. Results were analyzed by using X2, t test, Mann-Whitney and logistic regression. Results Mean age of patients was 25.2 ± 4.2 years and BMI was 26.2 ± 3.8. Patients had 60% hirsutism, 93% oligomenorrhea and 80% infertility. AMH levels before treatment with metformin was equal to 10 ± 3.75 and after treatment was 7.8 ± 3.7 which decreased significantly (P=0.008). Conclusion The results of this study showed that metformin for 2 months could decrease AMH significantly.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

Serum and follicular anti-Mullerian hormone levels in women with polycystic ovary syndrome (PCOS) under metformin

BACKGROUND No data regarding metformin effects on follicular fluid anti-Müllerian hormone (AMH) levels were to date available in literature. The aim of the present study was to evaluate in patients with polycystic ovary syndrome (PCOS) whether metformin administration affects serum and follicular AMH levels, and whether this is related to ovarian response to the treatment. METHODS Twenty youn...

full text

Role of Anti-Mullerian Hormone (AMH) in Polycystic Ovary Syndrome (PCOS)? A Mini Review

PCO affects about 10% of females. Increase in the burden of PCOS has led to a considerable amount of research into its risk factors, pathophysiology and the management [2]. There have been numerous theories that have been put forward for describing the etiology for an ovulation in PCO including; an excess of small antral follicles, hyperandrogenaemia, hyperinsulinaemia and dysfunctional feedbac...

full text

Effect of metformin on the anti-Müllerian hormone level in infertile women with polycystic ovarian syndrome

Background Polycystic ovary syndrome (PCOS) is the major cause of anovulatory infertility in women. The level of serum Anti-Mullerian Hormone (AMH) in patients can be 2-3 times higher than in healthy women. The aim of this study was to assess the effect of metformin on AMH level in PCOS patients suffering from infertility. Methods In this pre and post clinical trial, 30 infertile patients wit...

full text

Relationship between Serum Levels of Anti-Mullerian Hormone, Adiponectin and Oxidative Stress Markers in Patients with Polycystic Ovary Syndrome

Background: Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in women of reproductive age. Anti-Mullerian hormone (AMH) is a valid indicator of ovarian function and is used for PCOS diagnosis. Some studies have shown that adipokines affect the synthesis of AMH, and therefore they are somehow related in function. The aim of the present study was to determine the relationshi...

full text

Effect of Metformin on Serum Ferritin Level in Women with Polycystic Ovary Syndrome

BACKGROUND Polycystic ovary syndrome (PCOS) is one of the most common diseases among women associat-ed with various inflammatory reactants such as C-reactive protein (CRP) and ferritin. This study aimed to investi-gate the effect of metformin on probable reduction of serum ferritin in patients with PCOS. METHODS This study was conducted on 45 patients with PCOS who had not other systemic dise...

full text

Anti-Müllerian hormone in women with polycystic ovary syndrome.

Anti-Müllerian hormone (AMH) is a glycoprotein produced in the granulosa cells of the ovary. It is involved in the regulation of follicular growth and development. AMH serum and follicular fluid concentration is increased in women with polycystic ovary syndrome (PCOS), which correlates with the extent of ovarian dysfunction and clinical manifestation of the syndrome. It is unclear whether the h...

full text

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}


Journal title

volume 9  issue 2

pages  79- 79

publication date 2015-09-01

By following a journal you will be notified via email when a new issue of this journal is published.

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023